[1] |
TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics,2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
DOI
URL
|
[2] |
SHIOVITZ S, KORDE L A. Genetics of breast cancer:a topic in evolution[J]. Ann Oncol, 2015, 26(7):1291-1299.
DOI
URL
|
[3] |
张前进, 胡金娥, 胡一川, 等. 血清降脂素及维生素D与2型糖尿病患者胰岛β细胞功能及胰岛素敏感性的相关性[J]. 检验医学, 2020, 35(9):908-911.
|
[4] |
何珊, 邓露, 蔡志福, 等. 脂联素对高脂饮食诱导的胰岛素抵抗子宫内膜癌裸鼠移植瘤生长的影响[J]. 中国癌症防治杂志, 2020, 12(2):186-190.
|
[5] |
JOGIE-BRAHIM S, FELDMAN D, OH Y. Unraveling insulin-like growth factor binding protein-3 actions in human disease[J]. Endocr Rev, 2019, 30(5):417-437.
DOI
URL
|
[6] |
LANDREH M, STUKENBORG J B, WILLANDER H, et al. Proinsulin C-peptide interferes with insulin fibril formation[J]. Biochem Biophys Res Commun, 2012, 418(3):489-493.
DOI
URL
|
[7] |
NISHIHARA K, SUZUKI Y, ROH S. Ruminal epithelial insulin-like growth factor-binding proteins 2,3,and 6 are associated with epithelial cell proliferation[J]. Anim Sci J, 2020, 91(1):e13422.
|
[8] |
KRIEGE M, SEYNAEVE C, MEIJERS-HEIJBOER H, et al. Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers[J]. J Clin Oncol, 2009, 27(23):3764-3771.
DOI
URL
|
[9] |
LI Y, ZHAO D, LI Y, et al. Serum C-peptide as a key contributor to lipid-related residual cardiovascular risk in the elderly[J]. Arch Gerontol Geriatr, 2017, 73:263-268.
DOI
URL
|
[10] |
LEE K, KRUPER L, DIELI-CONWRIGHT C M, et al. The impact of obesity on breast cancer diagnosis and treatment[J]. Curr Oncol Rep, 2019, 21(5):41.
DOI
URL
|
[11] |
SPIELMAN L J, LITTLE J P, KLEGERIS A. Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration[J]. J Neuroimmunol, 2014, 273(1-2):8-21.
DOI
URL
|
[12] |
COHEN D H, LEROITH D. Obesity,type 2 diabetes,and cancer:the insulin and IGF connection[J]. Endocr Relat Cancer, 2012, 19(5):F27-F45.
DOI
URL
|
[13] |
REDDY R C, HAO Y, LEE S H, et al. Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS(-/-) mice:therapy for exocrine pancreatic disorders?[J]. Am J Physiol Gastrointest Liver Physiol, 2007, 293(1):G112-G120.
DOI
URL
|
[14] |
VISH M G, MANGESHKAR P, PIRAINO G, et al. Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice[J]. Crit Care Med, 2007, 35(5):1348-1355.
DOI
URL
|
[15] |
WANG E A, CHEN W Y, WONG C H. Multiple growth factor targeting by engineered insulin-like growth factor binding protein-3 augments EGF receptor tyrosine kinase inhibitor efficacy[J]. Sci Rep, 2020, 10(1):2735.
DOI
URL
|
[16] |
ZHANG M Q, GAO J L, LIAO X D, et al. MiR-454 regulates triglyceride synjournal in bovine mammary epithelial cells by targeting PPAR-γ[J]. Gene, 2019, 691:1-7.
DOI
URL
|
[17] |
LIANGGENG X, BAIWU L, MAOSHU B, et al. Impact of interaction between PPAR alpha and PPAR gamma on breast cancer risk in the Chinese Han population[J]. Clin Breast Cancer, 2017, 17(5):336-340.
DOI
URL
|
[18] |
AL-RASHEED N M, CHANA R S, BAINES R J, et al. Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells:dependent on phosphatidylinositol 3-kinase activity[J]. J Biol Chem, 2004, 279(48):49747-49754.
DOI
URL
|
[19] |
ZHAO J, ZHI Z, WANG C, et al. Exogenous lipids promote the growth of breast cancer cells via CD36[J]. Oncol Rep, 2017, 38(4):2105-2115.
DOI
URL
|
[20] |
CUI P, CHEN Y, WAILI N, et al. Associations of serum C-peptide and insulin-like growth factor binding proteins-3 with breast cancer deaths[J]. PLoS One, 2020, 15(11):e0242310.
DOI
URL
|
[21] |
SISTI G, DI TOMMASO M, PACCOSI S, et al. Unique associations between insulin-like growth factor binding protein-1,insulin-like growth factor-1 and T cell immunoglobulin Mucin 3 in successful twin pregnancies conceived with donor oocytes[J]. Medicina (Kaunas), 2019, 55(5):144.
|
[22] |
YANG J, HU Y, WU J, et al. Effects of IGFBP-3 and GalNAc-T14 on proliferation and cell cycle of glioblastoma cells and its mechanism[J]. J Pharm Pharmacol, 2020, 72(2):218-226.
DOI
URL
|
[23] |
CAI Q, DOZMOROV M, OH Y. IGFBP-3/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer[J]. Cells, 2020, 9(5):1261.
DOI
URL
|
[24] |
BURGER A M, LEYLAND-JONES B, BANERJEE K, et al. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer[J]. Eur J Cancer, 2005, 41(11):1515-1527.
DOI
URL
|
[25] |
RAVAL A, TRIVEDI S. Breast cancer:role of IGF-1 and IGFBP-3 expression in prognostication[J]. Indian J Exp Biol, 2016, 54(10):619-629.
|
[26] |
PROBST-HENSCH N M, STEINER J H, SCHRAML P, et al. IGFBP2 and IGFBP3 protein expressions in human breast cancer:association with hormonal factors and obesity[J]. Clin Cancer Res, 2010, 16(3):1025-1032.
DOI
URL
|
[27] |
RENEHAN A G, ZWAHLEN M, MINDER C, et al. Insulin-like growth factor(IGF)-I,IGF binding protein-3,and cancer risk:systematic review and meta-regression analysis[J]. Lancet, 2004, 363(9418):1346-1353.
DOI
URL
|
[28] |
GHORBANI A, SHAFIEE-NICK R, ZOJAJI S A, et al. Physiological effects of proinsulin-connecting peptide in human subcutaneous adipose tissue[J]. Physiol Int, 2017, 104(2):193-205.
DOI
URL
|
[29] |
YOSTEN G L, KOLAR G R, REDLINGER L J, et al. Evidence for an interaction between proinsulin C-peptide and GPR146[J]. J Endocrinol, 2013, 218(2):B1-B8.
DOI
URL
|
[30] |
ZHANG A M Y, WELLBERG E A, KOPP J L, et al. Hyperinsulinemia in obesity,inflammation,and cancer[J]. Diabetes Metab J, 2021, 45(3):285-311.
DOI
URL
|